cerivastatin and Sleep-Apnea--Obstructive

cerivastatin has been researched along with Sleep-Apnea--Obstructive* in 1 studies

Other Studies

1 other study(ies) available for cerivastatin and Sleep-Apnea--Obstructive

Article	Year
Severe obstructive sleep apnea after cerivastatin therapy: a case report. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008, Jun-15, Volume: 4, Issue:3 All available 3-hydroxy-3-methyglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) have been implicated in causing rhabdomyolysis either as monotherapy or in combination with other myotoxic drugs such as cyclosporine, colchicine and fibrates. Cerivastatin (Baycol) is a third generation statin, which has been implicated in cases of fatal rhabdomyolysis. It was voluntary withdrawn from the U.S. market by Bayer after reports of fatal rhabdomyolysis appeared in the literature. We present here a case of an 85-year-old woman who developed rhabdomyolysis and severe obstructive sleep apnea (OSA) symptoms after having been started on cerivastatin therapy for hypercholesteremia. Topics: Aged, 80 and over; Female; Humans; Hypolipidemic Agents; Polysomnography; Pyridines; Severity of Illness Index; Sleep Apnea, Obstructive	2008

Article

Year

Severe obstructive sleep apnea after cerivastatin therapy: a case report.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008, Jun-15, Volume: 4, Issue:3

All available 3-hydroxy-3-methyglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) have been implicated in causing rhabdomyolysis either as monotherapy or in combination with other myotoxic drugs such as cyclosporine, colchicine and fibrates. Cerivastatin (Baycol) is a third generation statin, which has been implicated in cases of fatal rhabdomyolysis. It was voluntary withdrawn from the U.S. market by Bayer after reports of fatal rhabdomyolysis appeared in the literature. We present here a case of an 85-year-old woman who developed rhabdomyolysis and severe obstructive sleep apnea (OSA) symptoms after having been started on cerivastatin therapy for hypercholesteremia.

Topics: Aged, 80 and over; Female; Humans; Hypolipidemic Agents; Polysomnography; Pyridines; Severity of Illness Index; Sleep Apnea, Obstructive

2008